Therapeutic Potential of Kava in the Treatment of Anxiety Disorders

  title={Therapeutic Potential of Kava in the Treatment of Anxiety Disorders},
  author={Yadhu N. Singh and Nirbhay N. Singh},
  journal={CNS Drugs},
Anxiety disorders are among the most common psychiatric disorders that affect all age groups of the general population. Currently, the preferred treatment is with pharmacological drugs that have antidepressant or anti-anxiety properties. However, these agents have numerous and often serious adverse effects, including sedation, impaired cognition, ataxia, aggression, sexual dysfunction, tolerance and dependence. Withdrawal reactions on termination after long-term administration are also a major… 
Kava as a Pharmacotherapy of Anxiety Disorders: Promises and Concerns
Overall, kava has a great potential to be developed as a natural anxiolytic agent through a systematic approach, but the present form should be used with caution.
Treatment of anxiety and depression: medicinal plants in retrospect
This review summarizes reports on the fundamentals, prevalence, diagnosis, neurobiology, advancement in treatment of these diseases and preclinical assessment of botanicals through bibliographic investigation of scientific journals, books, electronic sources, unpublished theses and electronic medium such as ScienceDirect and PubMed.
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
A lack of randomized double-blind placebo- controlled trials for anxiety disorders and few studies comparing novel treatments to existing anxiolytic agents suggests that there needs to be further expansion in research of these novel pathways and larger-scale studies of promising agents with positive results from smaller trials.
Insomnia: Differential Diagnosis and Current Treatment Approach
Recently developed hypnotics, exerting primary effects at the α1 subtype GABA-A receptor system, have been shown to have long-term efficacy as well as low toxicity, low addictive and overdose potential.
Herbal medicines in the treatment of psychiatric disorders: a systematic review
  • J. Sarris
  • Psychology, Medicine
    Phytotherapy research : PTR
  • 2007
This paper reports a critical review of 27 herbal medicines and formulas in treating a broad range of psychiatric disorders (in addition to anxiety and depression), including obsessive‐compulsive,
GABA‐modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence
Preclinical and clinical evidence is revealed for various phytomedicines modulating GABA‐pathways, with comparative anxiolytic effect to the current array of pharmaceuticals, along with good safety and tolerability profiles.
An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava
Overall, in this scoping review, several aspects of kava efficacy and safety are discussed and some pertinent issues related to kava consumption are identified.
Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
Current evidence supports the use of SJW in treating mild-moderate depression, and for kava in treatment of generalized anxiety, and any evidence of efficacy, mode of action, pharmacokinetics, safety and use in major depressive disorder, bipolar disorder, seasonal affective disorder (SAD), generalized anxiety disorder, social phobia (SP), panic disorder (PD), obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD) is reviewed.
Kava: A Comprehensive Review of Efficacy, Safety, and Psychopharmacology
The current weight of evidence supports the use of kava in treatment of anxiety with a significant result occurring in four out of six studies reviewed, and more studies are required to assess comparative efficacy and safety versus established pharmaceutical comparators.


Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
The meta-analysis of three trials suggests a significant difference in the reduction of the total score on the Hamilton Rating Scale for Anxiety in favor of kava Extract, implying that kava extract is superior to placebo as a symptomatic treatment for anxiety.
Kava and Valerian in the treatment of stress‐induced insomnia
These compounds may be useful in the treatment of stress and insomnia but further studies are required to determine their relative roles for such indications.
[Treatment of perioperative anxiety in suspected breast carcinoma with a phytogenic tranquilizer].
It is concluded that the herbal preparation Kavosporal forte is well suited of amelioration of the anxiety that arises regularly in connection with a mammary biopsy.
Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats
Kava extract versus placebo for treating anxiety
Compared with placebo, kava extract is an effective symptomatic treatment for anxiety although, at present, the size of the effect seems small and the effect lacks robustness and is based on a relatively small sample.
Kava-kava extract in anxiety disorders: an outpatient observational study.
Results support kava-kava extract as an effective and safe alternative to antidepressants and tranquilizers in anxiety disorder without the tolerance problems associated with benzodiazepines.
Use and abuse of the benzodiazepines.
  • A. Fraser
  • Medicine, Psychology
    Therapeutic drug monitoring
  • 1998
Benzodiazepines will continue to have an important role in clinical medicine, however, their clinical use should be monitored more closely because of the greater awareness of their adverse effects after long-term use andBecause of the potential for misuse and abuse.
Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin - A double-blind placebo-controlled study of four weeks treatment.
The efficacy of Cavain in patients suffering from anxiety.
A significant superiority of Cavain in comparison to placebo could be found and Cavain acted anxiolytically and promotive on the subjective vitality-related performance.
Risks and Benefits of Long‐Term Benzodiazepine Use
National survey data from consumers, laboratory data on the drug preferences of normal subjects, and a controlled clinical study of long-term diazepam treatment and withdrawal suggest that the risks of overuse, dependence, and addiction with benzodiazepines are low.